Subclinical thyroid condition associated with increased cardiovascular mortality

April 29, 2013

Having high thyroid activity, and even "high-normal" levels, is a significant risk factor for cardiovascular and all-cause mortality, according to work which has received an award at the European Congress of Endocrinology in Copenhagen.

Subclinical hyperthyroidism is diagnosed when the levels of (TSH) are low, but the free hormones (T4) and triiodothyronine (T3) are within normal range. You may have no symptoms at all, or symptoms such as the classical symptoms of an overactive thyroid - weight loss, higher blood pressure, nervousness, etc. These symptoms may be mild. TSH is produced as a signal from the pituitary gland to produce more , so low TSH implies that the body sees that your thyroid is tending to overactivity.

Now a group of Danish researchers led by Dr Christian Selmer studied the thyroid test results of more than half a million individuals who underwent thyroid testing in Copenhagen between 2000 and 2009. They found that those with subclinical hyperthyroidism were significantly more likely to die from cardiovascular disease. They also found that even patients having only slightly elevated thyroid activity, but still within the range which would be considered normal, showed a tendency to higher cardiovascular and other mortality.

The group looked at the results of 574,595 patients who had undergone testing. 95.9% of these patients showed normal . However 6,264 patients exhibited subclinical hyperthyroidism, 706 of whom subsequently died of various causes. According to Christian Selmer:

"According to our work, 15% of deaths in the subclinical group could be attributed to the condition."

Even those at the high end of the normal range showed an increase in mortality. There were 13,434 patients in this range. 1,013 of these died of various causes, with 17% of the deaths associated with the thyroid condition. The authors emphasised that it is difficult to put exact numbers on the actual excess deaths caused by the condition for a variety of reasons. They state that they do not know if treatment of these conditions will in fact eliminate these excess deaths. This will be the goal of further studies.

Dr Christian Selmer, Research Fellow at Gentofte University Hospital, Denmark, and a winner of a Young Investigator Award at the European Congress of Endocrinology, said:

"Let's keep this in context. Of the more than half million people who were tested, 50,612 subsequently died from all causes. According to our figures, this includes around 278 deaths which can be attributed to the subclinical thyroid or "high-normal" conditions we looked at, but it is important to remember that this is a calculated figure; we can't point to an individual and say he or she died because of the condition, and is one of many . Nevertheless, this needs to be taken seriously. I think that the take-home message is that if a person has a family history with any thyroid problem, or has any signs of thyroid problems, then they should go for a check-up. More than that, their family doctors need to be aware that any sign of abnormality can affect cardiovascular health, and they should act accordingly".

Explore further: Thyroid problems linked to irregular heart rhythm

More information:

Subclinical hyperthyroidism and risk of cardiovascular and all-cause mortality, Christian Selmer, Jonas Olesen, Jesper Madsen, Jens Faber, Peter Hansen, Ole Pedersen, Morten Hansen, Christian Torp-Pedersen, Gunnar Gislason

Background: It is still discussed if subclinical hyperthyroidism and "high-normal" thyroid function are risk-factors for cardiovascular mortality.
Objectives: To examine the risk of cardiovascular and all-cause mortality in relation to subclinical hyperthyroidism.
Methods: Patients consulting their general practitioner from 2000–2009 in Copenhagen, Denmark, who underwent thyroid blood tests, were identified by individual-level linkage of nationwide registries. Patients with a history of thyroid disease or related medication were excluded. Risk of cardiovascular mortality was analyzed using Kaplan-Meier curves and Poisson regression models were applied to estimate Incidence Rate Ratios (IRR).
Results: Of 574,595 included individuals (mean age 48.7 years [SD ±18.3]; 39.1% males) 550,927 (95.9%) were euthyroid, 1,603 (0.3%) had overt hypothyroidism, 11,834 (2.1%) subclinical hypothyroidism, 3,967 (0.7%) overt hyperthyroidism and 6,264 (1.1%) subclinical hyperthyroidism. Increased risk of cardiovascular mortality was found in two levels of subclinical hyperthyroidism (TSH <0.1, 0.1–0.2 mU/L and normal free thyroixine): IRR 1.24 [95% CI: 1.09–1.41], IRR 1.21 [1.09–1.34] and in "high-normal" levels of euthyroidism (TSH 0.2–0.4 mU/L): IRR 1.21 [1.13–1.29].
Conclusions: Subclinical hyperthyroidism and "high-normal" thyroid function are significant risk-factors for cardiovascular and all-cause mortality.

Related Stories

Thyroid problems linked to irregular heart rhythm

November 28, 2012
People with an overactive thyroid gland (hyperthyroidism) carry a greater risk of developing irregular heart rhythm (known as atrial fibrillation) than those with normal thyroid function, finds a study published on BMJ today.

Elderly may be more likely to die if they have subclinical hyperthyroidism

June 6, 2011
A common hormone abnormality in older adults -- a mild form of overactive thyroid called subclinical hyperthyroidism -- is linked to a much higher risk of dying, a new study finds. The results will be presented Sunday at ...

Mild increases in thyroid-stimulating hormone not harmful in the elderly

September 13, 2012
There is no evidence to link mildly elevated thyroid-stimulating hormone (TSH) levels to an increase in mortality among the elderly, according to a recent study accepted for publication in The Endocrine Society's Journal ...

Thyroid condition linked to heart problems: study

April 25, 2012
(HealthDay) -- New evidence suggests that a type of overactive thyroid condition appears to boost the risk of heart problems, especially atrial fibrillation (a form of irregular heartbeat) and premature death.

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.